Maine becomes the latest state to adopt a law seeking transparency on drug pricing

first_imgPharmalot Ed Silverman STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Log In | Learn More [email protected] You can add Maine to the growing list of states that have passed a law seeking more transparency about prescription drug pricing.However, unlike a few states that quickly required drug makers to provide cost and pricing information about their medicines – California, Vermont, Nevada, and Oregon — Maine is taking a two-step approach. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED What’s included? By Ed Silverman May 2, 2018 Reprints What is it?center_img Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. @Pharmalot GET STARTED Maine becomes the latest state to adopt a law seeking transparency on drug pricing Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. Joe Raedle/Getty Images About the Author Reprints Tags drug pricinglegalpharmaceuticalsSTAT+stateslast_img


Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top